April 13, 2021
April 13, 2021 – The U.S. FDA has given accelerated approval to Trodelvy® (sacituzumab govitecan-hziy), manufactured by Gilead, for a new indication to treat locally advanced or
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
April 13, 2021
April 13, 2021 - Global Reach Health, committed to giving back to the community and beyond, hosted a donation drive this past week, for necessary supplies needed in Guatemala.
April 7, 2021
April 7, 2021 – The U.S. FDA has granted full approval for Trodelvy® (sacituzumab govitecan-hziy), manufactured by Gilead, to treat unresectable locally
April 7, 2021
April 7, 2021
April 6, 2021
April 6, 2021 – The U.S. FDA has approved a new dosing regimen for Erbitux® (cetuximab), manufactured by ImClone. The drug may now be administered once every two weeks to treat
April 2, 2021
April 2, 2021 – A-S Medication Solutions (ASM) has voluntarily recalled 198,350 bottles of Acetaminophen Extra Strength 500mg Tablets, 100-count bottles (NDC# 50090-5350-0)
April 2, 2021
April 2, 2021 – The U.S. FDA has approved Qelbree® (viloxazine) extended-release oral capsules, manufactured by Supernus Pharmaceuticals, to treat attention